Bruce Keyser, MD
Retina Specialist · New Brunswick, NJNPI 1558334359
Payments from drug & device makers
What this record shows
This record is dominated by other: $5,775 of the $7,947 with a category attached, or 72.7%. Carl Zeiss Meditec USA, Inc. accounts for 72.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $5,795 and has fallen 97.4% since, to $149 in 2025.
Across 24 payments — averaging $331.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec USA, Inc.$6K
- Carl Zeiss Meditec, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$199
- Eyepoint US, Inc.$116
- Apellis Pharmaceuticals, Inc.$47
- Alimera Sciences, Inc.$37
- plus $71 from 4 others
What the payments were for
- Food & beverage$4696%
- Gifts$1,70221%
- Other$5,77573%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 1 | $5,775 |
| Carl Zeiss Meditec, Inc. | 1 | $1,702 |
| Regeneron Healthcare Solutions, Inc. | 12 | $199 |
| Eyepoint US, Inc. | 2 | $116 |
| Apellis Pharmaceuticals, Inc. | 2 | $47 |
| Alimera Sciences, Inc. | 2 | $37 |
| Samsara Vision | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Bausch & Lomb Americas Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clarus 700$5,775
- CLARUS$1,702
How this compares
$7,947 in reported general payments places this provider in the 65th percentile of 35 retina specialist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 112 | $3,270 |
| Prednisolone Acetate | 71 | $3,268 |
| Bromfenac Sodium | 14 | $2,585 |
| Loteprednol Etabonate | 11 | $2,181 |
| Brimonidine Tartrate | 36 | $879 |
| Atropine Sulfate | 16 | $526 |
| Timolol Maleate | 32 | $470 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $248 |
| Latanoprost | 18 | $172 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in New Brunswick
- Howard FineNew Brunswick$955K
- Jonathan PrennerNew Brunswick$215K
- Daniel RothNew Brunswick$61K
- Sumit ShahNew Brunswick$41K
- Harold WheatleyNew Brunswick$13K
- Eric FriedmanNew Brunswick$554
- Stuart GreenNew Brunswick$22
- Joshua MaliFlemington$230K
- Leonard FeinerUnion$72K
- Vatsal DoshiMillburn$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.